Insomnia Through the NSI Lens

Insomnia is not simply the absence of sleep. It is the presence of a nervous system that has learned to predict threat at the threshold of rest. The clinical definition—difficulty initiating or maintaining sleep, accompanied by daytime impairment, occurring at least three nights per week for three months—captures the pattern but not the mechanism. What distinguishes insomnia from ordinary sleeplessness is its self-perpetuating architecture: the bed becomes a context for arousal rather than safety, and the attempt to sleep triggers the very vigilance that prevents it.

The dominant framework in sleep medicine is cognitive-behavioral, and it has earned its place. Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment recommended by the American College of Physicians and supported by decades of trial data. It works by restructuring sleep-related beliefs and behaviors—stimulus control, sleep restriction, cognitive restructuring. But the nervous system perspective offers something the cognitive model does not fully account for: insomnia is not a failure of thought or habit alone. It is a prediction error that has calcified into physiology. The body has learned that lying down means danger, and it responds accordingly—heart rate variability drops, cortisol remains elevated, the autonomic system holds the line against a collapse it has been trained to fear. Understanding insomnia through the lens of Nervous System Intelligence means recognizing it as an intelligent, if costly, adaptation—one that can be revised.

Insomnia affects approximately one-third of adults globally, with chronic insomnia disorder meeting diagnostic criteria in roughly ten percent. The economic burden is staggering—estimated at over one hundred billion dollars annually in the United States alone when accounting for healthcare costs, lost productivity, and accident risk. But the human cost is harder to quantify. Chronic insomnia is not a benign inconvenience. It is a robust predictor of major depressive disorder, generalized anxiety disorder, substance use, cardiovascular disease, and all-cause mortality. The relationship is bidirectional and reinforcing: insomnia increases the risk of psychiatric illness, and psychiatric illness worsens insomnia.

For clinicians, insomnia presents a diagnostic and therapeutic challenge. It is rarely a standalone condition. It co-occurs with pain, trauma, mood disorders, neurodegenerative disease, and metabolic dysfunction. Treating insomnia in isolation often fails because the nervous system's threat prediction is embedded in a broader context of dysregulation. Pharmacologic interventions—benzodiazepines, Z-drugs, sedating antidepressants, orexin antagonists—can suppress symptoms but do not revise the underlying prediction. They sedate the system without teaching it safety.

The shift toward viewing insomnia as a disorder of hyperarousal rather than sleep deficiency has clinical traction. Hyperarousal is measurable: elevated beta and gamma EEG activity during sleep-onset periods, increased whole-body metabolic rate, higher core body temperature, elevated hypothalamic-pituitary-adrenal axis activity. These are not cognitive distortions. They are physiological states. The nervous system is doing exactly what it has been trained to do—stay awake to stay alive. This reframing matters because it changes the intervention. The goal is not to force sleep. It is to revise the prediction that rest is dangerous. That requires a different kind of precision.

The hyperarousal model of insomnia has gained empirical support across multiple levels of analysis. A 2022 meta-analysis in *Lancet Psychiatry* synthesized data from thirty-seven studies and confirmed that individuals with insomnia exhibit elevated sympathetic nervous system activity, reduced heart rate variability, and increased cortisol secretion during pre-sleep and sleep periods compared to controls (Palagini et al., 2022). These findings are consistent with a nervous system in a sustained state of threat prediction.

Neuroimaging studies have added anatomical specificity. A 2023 study in *JAMA Psychiatry* using resting-state functional MRI found that individuals with chronic insomnia showed hyperconnectivity between the amygdala and the default mode network, alongside reduced connectivity between the prefrontal cortex and subcortical arousal centers (Zhang et al., 2023). The authors interpreted this as a failure of top-down inhibition—an inability to down-regulate threat detection when contextually appropriate. This aligns with the prediction-error framework: the system continues to predict danger because the revision signal from the cortex is insufficient to override subcortical learning.

Polysomnographic studies reveal a mismatch between subjective and objective sleep in a subset of insomnia patients, a phenomenon sometimes termed paradoxical insomnia. A 2021 study in *Sleep Medicine Reviews* proposed that this mismatch reflects heightened interoceptive sensitivity and attentional bias toward internal arousal cues, rather than fabrication or exaggeration (Rezaie et al., 2021). The nervous system is detecting real signals—micro-arousals, autonomic fluctuations—that would not breach awareness in individuals without insomnia. The prediction is accurate; the problem is the prediction itself.

Cognitive Behavioral Therapy for Insomnia remains the most robustly supported intervention. A 2022 network meta-analysis in *The BMJ* including fifty-nine randomized controlled trials found that CBT-I produced moderate to large effect sizes on sleep-onset latency, wake after sleep onset, and sleep efficiency, with effects sustained at six- and twelve-month follow-up (Soh et al., 2022). The mechanisms are well-characterized: stimulus control re-pairs the bed with sleep rather than wakefulness; sleep restriction increases homeostatic sleep pressure; cognitive restructuring targets catastrophic beliefs about sleeplessness.

But CBT-I does not work for everyone. Response rates hover around sixty to seventy percent, and a significant minority show no benefit. A 2023 study in *Biological Psychiatry* examined whether baseline autonomic tone predicted CBT-I response and found that individuals with the highest pre-treatment heart rate variability—a marker of parasympathetic capacity—were significantly more likely to respond (Kalmbach et al., 2023). This suggests that the capacity to down-regulate arousal may be a prerequisite for cognitive-behavioral change, not merely an outcome of it.

Pharmacologic approaches continue to evolve. Dual orexin receptor antagonists, approved in the past five years, represent a mechanistic departure from GABAergic sedation. A 2022 trial in *The New England Journal of Medicine* found that lemborexant improved sleep-onset and sleep maintenance without next-day residual sedation or rebound insomnia upon discontinuation (Mignot et al., 2022). The drug works by blocking orexin signaling, which promotes wakefulness. It does not sedate; it removes a wake signal. Whether this constitutes prediction revision or mere symptom suppression remains an open question.

Emerging evidence points to the role of circadian misalignment. A 2023 study in *Nature Medicine* using wearable actigraphy and salivary melatonin sampling found that nearly forty percent of individuals with chronic insomnia had delayed circadian phase relative to their desired sleep time, independent of sleep-onset latency (Phillips et al., 2023). The nervous system was not hyperaroused at the wrong time—it was appropriately aroused at the right circadian time, but misaligned with social schedules. The prediction was accurate; the context was incompatible.

Nervous System Intelligence proposes that the nervous system is a prediction engine, continuously generating models of the world and revising them in response to prediction error. Insomnia, in this framework, is not a disorder of sleep but a disorder of prediction. The nervous system has learned that the transition to sleep—a state of reduced vigilance and motor control—is unsafe. That learning may have originated in trauma, chronic stress, pain, or repeated experiences of vulnerability during rest. Once established, the prediction becomes self-confirming. The bed triggers arousal, arousal prevents sleep, and the absence of sleep confirms the danger of trying.

This is not irrational. It is intelligent. The nervous system is doing what it was designed to do: prioritize survival over comfort. The problem is that the prediction is no longer contextually accurate. The threat that once justified hyperarousal may be absent, but the prediction persists because it has been encoded in autonomic, subcortical, and interoceptive pathways that do not update easily through conscious reasoning alone.

The NIRVA Method's six movements offer a structured protocol for prediction revision, and insomnia implicates all six—but most directly *Interrupt* and *Regulate*. Interrupt is the recognition that the arousal response at sleep onset is a prediction, not a fact. It is the moment of metacognitive distance: noticing that the racing heart, the scanning thoughts, the tension in the jaw are outputs of a model, not reflections of present danger. Interrupt does not suppress the arousal; it names it as a prediction in need of revision.

Regulate is the physiological work of providing the nervous system with evidence that contradicts the prediction. This is where stimulus control, sleep restriction, and autonomic interventions converge. Stimulus control teaches the system that the bed predicts sleep, not wakefulness. Sleep restriction increases homeostatic pressure to the point where sleep occurs despite arousal, providing a corrective prediction error. Breathwork, progressive muscle relaxation, and heart rate variability biofeedback offer direct autonomic input—signals that safety is present, that the system can afford to down-regulate.

Validate and Align are equally essential but often overlooked. Validate acknowledges that the hyperarousal is not a personal failing or a sign of weakness—it is an adaptation that once made sense. Align asks whether the desired sleep schedule is compatible with the nervous system's current circadian and autonomic state, or whether the mismatch itself is generating the prediction error. Insomnia is not always a problem to be solved. Sometimes it is a signal that the life being lived is misaligned with the nervous system attempting to live it.

For clinicians, the nervous system lens does not replace cognitive-behavioral or pharmacologic approaches—it contextualizes them. CBT-I works, but it works by revising predictions, not by correcting thoughts. Stimulus control is prediction revision through associative learning. Sleep restriction is prediction revision through homeostatic override. Cognitive restructuring is prediction revision through explicit reappraisal. Understanding the mechanism allows for more precise application and troubleshooting when standard protocols fail.

When CBT-I does not work, the question becomes: what is preventing prediction revision? Is the autonomic system too dysregulated to register safety signals? Is there ongoing trauma, pain, or threat that makes the prediction contextually accurate? Is the circadian system misaligned such that the nervous system is being asked to sleep when it is biologically primed for wakefulness? These are not cognitive questions. They require physiological assessment—heart rate variability, circadian phase markers, trauma history, autonomic tone.

Pharmacologic interventions can be reframed not as sleep aids but as scaffolding for prediction revision. A short course of a dual orexin receptor antagonist may allow the nervous system to experience sleep in the feared context, generating the prediction error necessary for learning. The goal is not chronic suppression but temporary support while the system recalibrates. This requires shared decision-making and explicit discussion of the role of medication within a broader revision process.

Clinicians should also consider the role of interoceptive training. Individuals with insomnia often exhibit heightened interoceptive sensitivity—they detect autonomic fluctuations that others do not. This is not pathological; it is a feature of a nervous system trained to monitor for threat. But it can be redirected. Biofeedback, body scan practices, and somatic tracking teach the system to observe arousal without interpreting it as danger. The prediction shifts from "this sensation means I will not sleep" to "this sensation is information, not instruction."

Finally, clinicians must validate the intelligence of the insomnia. The patient is not broken. The nervous system is doing what it was trained to do. The work is not to override it but to offer it new evidence, in a language it can understand—physiological, associative, contextual. That is the work of prediction revision, and it is the work that lasts.

If you live with insomnia, the first step is not to fight the arousal but to recognize it as a prediction. When you lie down and your heart rate climbs, when your mind begins to catalog every unfinished task, when your body tenses—notice that this is your nervous system predicting that rest is unsafe. It is not a fact. It is a model. That distinction is the beginning of revision.

Interrupt the prediction by naming it aloud or in writing: "My nervous system is predicting danger. That prediction made sense once. It may not make sense now." This is not positive thinking. It is metacognitive precision. You are not arguing with the arousal; you are observing it from a different vantage point.

Regulate by giving your nervous system evidence that contradicts the prediction. This may mean leaving the bed after fifteen minutes of wakefulness and returning only when sleepy—stimulus control. It may mean restricting your time in bed to match your actual sleep duration, even if that means five or six hours initially—sleep restriction. It may mean a three-minute box-breathing protocol before bed, or a body scan that teaches your system to observe tension without escalating it.

Validate the arousal. It is not a sign of failure. It is a sign that your nervous system has been trained to protect you, and it is still doing that job. The hyperarousal is intelligent. It is also revisable.

Align your sleep schedule with your circadian biology, not with social convention. If your nervous system is primed for wakefulness at eleven p.m., trying to sleep then is a prediction error waiting to happen. Experiment with later sleep and wake times if your life allows it. The goal is not to force the system into compliance but to find the schedule that allows revision to occur.

This is not a quick fix. Prediction revision takes time, repetition, and consistency. But it is possible. The nervous system that learned to fear rest can learn, with the right evidence, that rest is safe.